Stay updated with breaking news from டெரன்ஸ் சுய. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-Mail Leveraging on Asian patient data, the 5-year collaboration aims to boost patientcentricity in R&D, leading to improved treatment outcomes in cardiovascular disease (CVD) management. The Center will generate and integrate high quality patient data into early clinical research to inform future targeted therapies for CVDs. Bayer will contribute S$5.4million (approx. EUR 3.4 million) towards this collaboration. Singapore, December 17, 2020 - Bayer and National Heart Centre Singapore (NHCS) today announced that they have entered into a 5-year collaboration agreement to set up Center of Excellence for Explorative Cardiovascular Studies (hereinafter Center ) with the aim of boosting patient-centricity in research and development (R&D) and improving treatment outcomes in cardiovascular disease (CVD) management. Combining NHCS vast ....